Skip to main content
logo
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.735
+0.075 (4.52%)
Nov 6, 2026, 4:00 PM EST - Market closed

BDTX Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-70----
Revenue Growth
------
Gross Profit
-70----
Operating Income
-44.5619.87-78.78-86.46-92.83-126.87
Net Income
-42.5622.37-69.68-82.44-91.17-125.6
Earnings Per Share
-0.740.39-1.27-1.88-2.51-3.47
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
110.51128.6598.58131.4122.81209.79
Total Debt
16.9718.7822.1925.328.1428.46
Net Cash (Debt)
93.54109.8776.39106.194.67181.33
Net Cash Growth
-23.38%43.83%-28.00%12.08%-47.79%-40.81%
Net Cash Per Share
1.641.911.392.412.615.01

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-32.8429.61-62.3-66.72-85.08-100.15
Capital Expenditures
----0.03-0.19-2.71
Free Cash Flow
-32.8429.61-62.3-66.75-85.27-102.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%----
Operating Margin
-28.39%----
Pretax Margin
-31.95%----
Profit Margin
-31.95%----
FCF Margin
-42.31%----

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-6.19----
P/FCF Ratio
-4.68----
PS Ratio
-1.98----